CNS Drugs
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Key Metrics
Journal Specifications
- PublisherADIS INT LTD
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1994
- Publisher URL
- Website URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has CNS Drugs been publishing? 
The CNS Drugs has been publishing since 1994 till date.
How frequently is the CNS Drugs published?
CNS Drugs is published Monthly.
Who is the publisher of CNS Drugs?
The publisher of CNS Drugs is ADIS INT LTD.
How can I view the journal metrics of CNS Drugs on editage?
For the CNS Drugs metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of CNS Drugs?
The eISSN number is 1179-1934 and pISSN number is 1172-7047 for CNS Drugs.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Migraine, Central nervous system, Acetaminophen, Erythropoietin, Multiple sclerosis, Status epilepticus, Antipsychotic, Parkinson's disease, Confidence interval, Antidepressant, Cannabinoid, Adult patients, NADPH oxidase, Ischemic stroke, Fixed-dose combination, Placebo, Drug-induced glaucoma, Clinical trial, Ketamine, Systematic review.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.